Page 11 - ேசை இணை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oura banks $100M as adoption of wearable technology accelerates during COVID-19

May 5, 2021 9:45am Oura said it will continue to develop within new use cases focused on recovery, activity, illness, mental health and women’s health. Wearable technology also shows promise for helping manage sleep apnea and high blood pressure conditions. (Oura Ring) During the COVID-19 pandemic, the Oura Ring quickly shifted from being just a consumer wearable to a key research tool for early detection of COVID-19 symptoms. Oura Health s wellness ring was one of the first wearables used by an academic research institution, the University of California, San Francisco (UCSF), to potentially predict illness symptoms. The company also donated rings to front-line healthcare workers who were likely to be affected by the virus.

United statesSan franciscoEurie kimDaniel welchBedford ridgeShyamal patelPetteri lahtelaKari kivelHarpreet singh raiMarkku koskelaMarc benioffVirginia university rockefeller neuroscience instituteUniversity of californiaDepartment of defense innovation unitMetaplanet holdingsEisai co

Breast Cancer Therapeutics Market Size 2021 | Is Projected to Reach USD 55 27 Billion by 2027 with a CAGR of 13 1%

Share: Pune, India, May 04, 2021 (GLOBE NEWSWIRE) According to the report, Breast Cancer Therapeutics market size is projected to reach USD 55.27 Billion by 2027. Breast Cancer Therapeutics Market was worth USD 21.58 billion in 2019 and will exhibit a CAGR of 13.1% during the forecast period. Nowadays, several renowned companies are constantly launching new breast cancer therapeutics worldwide. Most of these drugs are meant for the treatment of those types of breast cancers that were previously untreatable or the available drugs were not successful for providing positive outcomes. However, certain severe reactions can come up while undergoing this type of cancer therapeutics, such as targeted therapies. Patients can suffer from nausea, fatigues, rashes, gastrointestinal problems, or high blood pressure. These may hinder growth.

New yorkUnited statesUnited kingdomAsia pacificAstrazeneca cambridgeEli lillyGenentechf hoffmannRoche ltd south san franciscoA sample copy of the researchCustomized researchEisai coBreast cancer therapeutics market researchMerck co incNuclear medicinePfizer incPharmacies stores

Epilepsy Foundation Collaborates with Eisai to Develop Epilepsy Digital Experience Navigator

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesRobert chuIvan cheungEpilepsy foundationWorld health organizationEisai incEisai coUs centers for disease control preventionNeurology business groupPrnewswire today the epilepsy foundationEpilepsy digital experience navigatorJacqueline frenchHuman healthcareDisease controlPr newswireஒன்றுபட்டது மாநிலங்களில்

Anti-Obesity Drugs Market Research Report - Global Forecast to 2025 - Cumulative Impact of COVID-19

Anti-Obesity Drugs Market Research Report - Global Forecast to 2025 - Cumulative Impact of COVID-19 Anti-Obesity Drugs Market Research Report - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. April 29, 2021 05:04 ET | Source: ReportLinker ReportLinker Lyon, FRANCE New York, April 29, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Anti-Obesity Drugs Market Research Report - Global Forecast to 2025 - Cumulative Impact of COVID-19 - https://www.reportlinker.com/p06067147/?utm source=GNW This helps organization leaders make better decisions when currency exchange data is readily available.

New yorkUnited statesUnited kingdomSouth africaUnited arab emiratesSaudi arabiaSouth koreaBoehringer ingelheim gmbZydus cadilaBristol myers squibbObesity drugs market researchMerck coEisai coVivus incTakeda pharmaceuticalsCurrax pharmaceuticals

Immunology Drug Market is in huge demand | Abbott Laboratories , Active Biotech , Eli Lilly and Company – KSU

Immunology Drug Market is in huge demand | Abbott Laboratories , Active Biotech , Eli Lilly and Company – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUnited kingdomCzech republicNew zealandSouth koreaRepublic ofSouth africaSaudi arabiaEli lillyTechnology cost analysisEisai coCompany immunology drug business distributionCompany immunology drug business introductionSanofi aventisBrowse premium research